WeissLaw is investigating whether CPHD's Board acted to maximize shareholder value prior to entering into the agreement. Notably, the offer price is lower than the Company's 52-week high of
Given these facts, WeissLaw is investigating whether CPHD's Board acted in the best interests of CPHD's public shareholders to maximize shareholder value prior to entering into the agreement. If you own CPHD shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cepheid-acquisition-may-not-be-in-the-best-interests-of-cphd-shareholders-300325666.html
SOURCE WeissLaw LLP